Stereotaxis (NASDAQ: STXS) is a healthcare technology and innovation leader in the development of robotic cardiology instrument navigation systems designed to enhance the treatment of arrhythmias, with $47 million in sales.Directed accounting, finance, manufacturing, sales operations, field service, sustaining engineering and information technology in a turnaround situation. Managed relationship with lenders and investment bankers. Obtained bank waivers and amendments. Served as primary interface with investment community and financial media. - Narrowed operating loss to $0.9 million and cash burn to $0.1 million, the best quarterly performance since going public in August 2004.- Evaluated financing alternatives, negotiated underwriting fees, performed road shows and ultimately obtained $10 million in common stock PIPE and $8.5 million in unsecured, subordinated convertible debentures enabling the repayment of $7 million in debt, extension of a $13 million revolving credit facility and funding of working capital.- Led and secured a $20 million royalty monetization financing with HealthCare Royalty Partners.- Achieved $19 million or 31% reduction in operating expenses, decreased operating loss by $21 million or 67% and lowered cash burn by $26 million or 68% while growing revenue $5 million or 11% with senior management team.- Developed and presented recommendations to Board of Directors on strategic and financing alternatives.- Led a tiger team to improve customer satisfaction for the installed customer base and clinical adoption team.

RehabCare (NYSE: RHB) - a leading provider of post-acute care - is the largest contract manager of rehabilitation services and the third-largest post-acute care hospital operator in the United States, with $1.3 billion in sales.Managed treasury, investor relations, financial analysis, budgeting and lease financing. Directed relationship with bank group and credit agencies. Served as primary interface with investment community. Created five-year financial models in support of acquisitions and sale of RehabCare. Led consolidated budget process. Reviewed and negotiated hospital facility lease terms and conditions. Contributed actively to monthly accounting close review meetings and served on disclosure committee. - Engaged in all aspects of Kindred Healthcare acquisition of RehabCare, resulting in 45% premium to shareholders. - Assessed financing alternatives, negotiated underwriting fees, selected debt and equity underwriters, drafted credit agreements and ultimately secured $575 million in debt and $149 million in equity financing for the $570 million acquisition of Triumph Healthcare, doubling EBITDA of RehabCare. - Expanded sell-side analyst coverage from five to nine. - Targeted and increased percentage of growth and GARP shareholders by 10%. - Revamped content and message to investment community, and significantly increased participation in investor conferences as well as non-deal road shows. - Developed and presented recommendations to Board of Directors on share repurchase, stock split, cost of capital, financing alternatives and interest rate hedging strategies. - Led integration of Triumph Healthcare cash management, standardizing account structures and fees, implementing positive pay on controlled-disbursement accounts and reducing costs by 27%.

Kellwood – one of the largest apparel makers in the United States – is a wholesaler/retailer of branded and private label men’s, women’s, children’s and infant’s apparel and leisure time outdoor products with $2 billion in sales.Directed treasury, investor relations, risk management, credit and collections, as well as chargebacks. Worked closely with investment bankers on strategic and financing alternatives. Obtained bank amendments. Managed relationships with bank group and credit agencies. Architected strategic and tactical investor communications. Reduced annual risk management costs by $750,000 while improving coverage. Developed credit levels for customers. Actively participated in monthly accounting close review meetings and served on disclosure committee. - Championed $4 million financial transformation initiative to reduce manual processes and rely on improved Oracle functionality and automation, resulting in two-year payback. - Partnered as key member of senior management in hostile-takeover defense as well as subsequent acquisition by Sun Capital, resulting in a 38% premium to shareholders. - Developed and organized treasury function, enabling implementation of $80 million accelerated share repurchase program and $60 million partial tender offer of public debt.

Managed credit/collections and chargebacks, as well as co-led treasury and investor relations. Oversaw daily cash management. Administered share repurchase program. Managed relationships with bank group and credit agencies. Crafted quarterly earnings releases and managed interface to investment community. Led development of credit levels for customers. Negotiated and standardized terms across operation divisions. Contributed actively to monthly accounting close review meetings and served on disclosure committee. - Developed and presented recommendations to Board of Directors on company’s cost of capital and dividend yield, as well as financing alternatives. - Created guidelines and invested up to $400 million in excess cash.- Won proxy contest for election of director against CaIPERS, Institutional Shareholder Services and Glass, Lewis & Co.

Led all strategic and operational activities involving divisional accounting, accounts payable, credit and collections, chargebacks and payroll. Built, maintained and supported high-performance team committed to maximizing service quality and customer satisfaction, as well as driving continuous performance improvement. Developed key performance indicators and established service-level agreements with operating divisions. - Created and executed plans to transition division functions to shared-services organization. - Expanded days payable outstanding within inventory vendors by 15 days.

MEMC (NYSE: WFR) is a global leader in the manufacture and sale of silicon wafers and related intermediate products to the semiconductor and solar industries, with $1 billion in sales.Directed management and oversight of domestic and international accounting operations, including SEC reporting, financial analysis and general accounting. Researched accounting issues, including proposed business combinations and related post-transaction implementation of purchase accounting. - Led implementation of Sarbanes-Oxley (SOX). - Co-led initiative to reorganize worldwide accounting organization and reduce cost while accelerating monthly financial statement closing process from +/- 5 days to +/- 2 days.

Led all merger and acquisition activities. Developed independent valuations and strategies for acquisition of target companies. Co-led $68 million acquisition of 55% interest, held by four parties, in Taiwanese joint venture not owned by MEMC. Led delegation to Mainland China for site selection and negotiation of financial incentives.

Directed merger and acquisitions activities. Led six-month purchasing and services spend reduction initiative with Bain Consulting and Texas Pacific Group (TPG), resulting in $20 million in services savings. Directed four-month initiative with Bain Consulting and TPG, resulting in selection of manufacturing sites for future rationalization. Achieved more than $100 million in cost reductions as part of executive team in conjunction with worst-ever downturn in silicon wafer industry history.

Developed models and business analyses to maximize profitability as well as cash flow. Initiated and directed analyses of impact to gross margin and cash flow of alternative product platforms. Led creation of key performance indicators using Balanced Scorecard.

Established investor relations function and presented at investment banking conferences. Managed interface with investment community and financial media. Contributed to $200 million private placement and rights offering as key member of financial management.

KPMG LLP - the U.S. audit, tax and advisory firm - operates from 87 offices with over 23,000 employees and partners.Directed audit engagements for middle-market to Fortune 150 public and private clients with domestic/international operations in the hi-tech, manufacturing, consumer products and financial services industries. Promoted five times to Audit Senior Manager. Earned recognition as one of the top performers by KPMG and selected for short-term rotation in Melbourne, Australia.